Why the new GLP-1 pill is such a big deal: The FDA just approved Foundayo. Here’s what it can and can’t do.2. April 2026
News Wolters Kluwer Launches Ovid Synthesis Expert AI to Accelerate Quality Improvement (QI) Projects –Healthradar30. Oktober 2025 What You Should Know: – Wolters Kluwer Health today announced the launch of new AI features in Ovid®Synthesis to further support nursing and…
